Get the Stockscreener App
197.66
0.80%
1.56
After Hours:
199.00
1.34
+0.68%
Iqvia Holdings Inc stock is traded at $197.66, with a volume of 1.09M.
It is up +0.80% in the last 24 hours and up +0.29% over the past month.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$196.10
Open:
$195.42
24h Volume:
1.09M
Relative Volume:
0.72
Market Cap:
$35.88B
Revenue:
$15.32B
Net Income/Loss:
$1.41B
P/E Ratio:
25.94
EPS:
7.62
Net Cash Flow:
$1.96B
1W Performance:
-3.26%
1M Performance:
+0.29%
6M Performance:
-15.16%
1Y Performance:
-7.07%
1-Day Range:
$194.06
$198.56
1-Week Range:
$194.06
$207.72
52-Week Range:
$187.62
$261.73
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
197.66 | 35.88B | 15.32B | 1.41B | 1.96B | 7.62 |
|
TMO
Thermo Fisher Scientific Inc
|
561.71 | 214.85B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
241.90 | 174.72B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
144.72 | 41.33B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
428.62 | 35.10B | 3.84B | 866.24M | 792.60M | 10.37 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
IQVIA (NYSE:IQV) Shares Gap DownTime to Sell? - MarketBeat
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance
Sendero Wealth Management LLC Buys 9,153 Shares of IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Assenagon Asset Management S.A. Has $50.23 Million Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Pallas Capital Advisors LLC Makes New $298,000 Investment in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
(IQV) Long Term Investment Analysis - Stock Traders Daily
Will IQVIA (IQV) Beat Estimates Again in Its Next Earnings Report? - MSN
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
IQVIA Holdings (IQV) Fell Due to Reduced Near-Term Outlook in its R&D Solutions - Yahoo Finance
Community Trust & Investment Co. Raises Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 42% Discount? - Simply Wall St
Clinical Trials Support Services Market Poised for Notable Expansion by 2030, Driven by Substantial Investments in R&D from Pharmaceutical and Biopharmaceutical Companies - GlobeNewswire Inc.
IQVIA partners with NVIDIA to advance AI in healthcare - Investing.com
IQVIA partners with NVIDIA to advance AI in healthcare By Investing.com - Investing.com UK
IQVIA Partners with NVIDIA to Transform Healthcare AI, Accelerate Drug Development - StockTitan
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA (NYSE:IQV) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Nordea Investment Management AB Raises Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
(IQV) On The My Stocks Page - Stock Traders Daily
Everence Capital Management Inc. Has $574,000 Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
IQVIA Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
IQVIA Benefits From Global IT Infrastructure Amid Low Liquidity - MSN
Possible Bearish Signals With IQVIA Holdings Insiders Disposing Stock - Yahoo Finance
IQVIA Holdings Inc. (NYSE:IQV) Short Interest Update - MarketBeat
Analysts Set IQVIA Holdings Inc. (NYSE:IQV) PT at $255.82 - MarketBeat
IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Matching Investor Opinion - Simply Wall St
IQVIA Holdings Inc. (NYSE:IQV) Position Boosted by JPMorgan Chase & Co. - MarketBeat
Investors in IQVIA Holdings (NYSE:IQV) have unfortunately lost 29% over the last three years - Yahoo Finance
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
(IQV) Investment Analysis - Stock Traders Daily
IQVIA Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
IQVIA (IQV) Surges 3.0%: Is This an Indication of Further Gains? - MSN
These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well - Yahoo Finance
M&T Bank Corp Lowers Position in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Is IQVIA Holdings Stock Underperforming the Nasdaq? - MSN
Stephens & Co. Initiates Coverage of IQVIA Holdings (IQV) with Overweight Recommendation - MSN
Stephens Initiates Coverage on IQVIA (NYSE:IQV) - MarketBeat
Wellington Management Group LLP Has $2.06 Million Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is IQVIA Holdings Stock Underperforming The Nasdaq? - Barchart
IQVIA Holdings Inc. (NYSE:IQV) Sees Large Drop in Short Interest - MarketBeat
Franklin Resources Inc. Boosts Holdings in IQVIA Holdings Inc. (NYSE:IQV) - MarketBeat
Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$199? - Yahoo Finance
William Blair Analysts Raise Earnings Estimates for IQVIA - MarketBeat
Boasting A 20% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock? - Simply Wall St
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):